Home > Browse Research > Life Sciences > Biotechnology > Antibody Technologies

Antibody Technologies: market research reports

Monoclonal antibodies (mAbs) are large protein molecules produced by white blood cells that seek out and destroy harmful foreign substances. Monoclonal antibodies are finding wide application in many areas of medicine and biologic science. These antibodies have begun to replace conventional antibodies in blood banking and are used in the identification of organisms in the bacteriology laboratory. Monoclonal antibodies have also been extensively used in radioimmunoassay to measure serum levels of various substances.

They have very useful in quantitating types of WBCs and subgroups of lymphocytes. They are also used in the diagnosis of leukemia. More recently, monoclonal antibodies have been used in the treatment of malignancies. They have been used to treat transplant rejection episodes, purge bone marrow of tumor cells in bone marrow transplants, and remove mature T cells that cause GVH disease in bone marrow transplants.

There are several types of monoclonal antibodies on the market and in development. Most of the monoclonal antibodies on the market are whole antibodies, while some are fragments of antibodies. There are also variable fragment monoclonal antibodies and bispecific monoclonal antibodies.

Antibody Technologies market research reports and industry analysis

Triple Analysis: Melanoma, Antibodies and Peptides 6/12/2013 \| published by: BioSeeker Group AB ... five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. ... \| read more...	$5,175.00
Triple Analysis: Melanoma, Cancer Vaccines and Antibodies 6/12/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Melanoma, Pancreatic Cancer and Antibodies 6/12/2013 \| published by: BioSeeker Group AB ... a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different ... \| read more...	$5,175.00
Triple Analysis: Melanoma, Protein Kinase Inhibitors and Antibodies 6/12/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Antibody Drug Conjugates Market, 2012-2023 5/31/2013 \| published by: Roots Analysis Pvt. Ltd. ... of drug developers, with several large and small companies entering the market through collaboration and licensing agreements with technology providers. The ADC market is still in its infancy. So far, three ADCs have received market ... \| read more...	$1,699.00
Conference Documentation: ADC Summit 2013 5/20/2013 \| published by: SMI Publishing, Ltd ... of targeted chemotherapy for the treatment of cancer. Anticipated use of ADCs over the next 5-10 years in set to increase by 40-50% specifically within cancer research. This huge surge in programme is down to ... \| read more...	$788.78
CompetitiveWatch Infectious Disease Testing: Strategic Profiles of Leading Suppliers 5/14/2013 \| published by: Venture Planning Group ... monoclonal antibodies, immunoassays, IT, gel microdroplets, differential light scaltering, chromatography and several others. The report also presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products, including their sales, product ... \| read more...	$3,500.00
Cancer Monoclonal Antibody Partnering Agreements - CP22012 - May2013v3 5/1/2013 \| published by: Current Partnering ... deals Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal antibody partnering contract documents Top cancer monoclonal antibody deals by value The Cancer Monoclonal Antibody Partnering Agreements report provides an understanding and ... \| read more...	$1,995.00
Monoclonal Antibody Markets in China 5/1/2013 \| published by: Asia Market Information & Development Company ... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in ... \| read more...	$2,000.00
Antibody Partnering Agreements - CP2113 - May2013v3 5/1/2013 \| published by: Current Partnering ... analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. ... \| read more...	$2,995.00
Analytical Tool - Apoptosis in Oncology 4/22/2013 \| published by: BioSeeker Group AB ... same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of ... \| read more...	$11,625.00
Analytical Tool - Antibodies and Peptides in Oncology 4/22/2013 \| published by: BioSeeker Group AB ... drug competitive landscape. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The ... \| read more...	$22,312.50
Analytical Tool - Cancer Immunotherapy 4/22/2013 \| published by: BioSeeker Group AB ... a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment ... \| read more...	$20,437.50
Analytical Tool - Cancer Therapeutic Antibodies 4/22/2013 \| published by: BioSeeker Group AB ... same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of ... \| read more...	$14,808.75
Antibodies in Oncology Drug Pipeline Update 2013 4/22/2013 \| published by: BioSeeker Group AB ... for the second wave in the lucrative field of therapeutic antibodies. There are today 303 companies plus partners developing 598 antibody drugs in 1408 developmental projects in cancer. In addition, there are 6 suspended drugs ... \| read more...	$5,621.25
2013 Analysis of the Pap Smear/HPV Testing Market: US, Europe (France, Germany, Italy, Spain, UK), Japan-- Emerging Opportunities, Country Forecasts, Innovative Technologies, and Competitive Landscape 4/17/2013 \| published by: Venture Planning Group ... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ... \| read more...	$4,350.00
Competitor Analysis: Antibody-Drug Conjugates (ADC) 4/1/2013 \| published by: La Merie Publishing ... of April 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent ... \| read more...	$785.00
Protein Engineering Market [Products (Monoclonal Antibody, Insulin Analog, Modified EPO), Technology (Sequential Modification, Glycosylation, PEGylation), and Applications (Therapeutics, Diagnostics, Research)] - Global Forecast to 2017 3/28/2013 \| published by: MarketsandMarkets ... are used as therapeutics. In order to improve their clinical potential, second generation recombinants are being developed, each exhibiting improved efficiency and potency depending on their applications. The global protein engineering technologies market (2012-2017) report ... \| read more...	$4,650.00
Triple Analysis: Lymphoma, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Colorectal Cancer, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Triple Analysis: Leukemia, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Lung Cancer, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus ... \| read more...	$5,175.00
Triple Analysis: Angiogenesis, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Apoptosis, Cancer Vaccines and Antibodies 3/19/2013 \| published by: BioSeeker Group AB ... to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area ... \| read more...	$5,175.00
Triple Analysis: Cancer Vaccines, Antibodies and Peptides 3/19/2013 \| published by: BioSeeker Group AB ... standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but ... \| read more...	$5,175.00

< prev 1 2 3 4 5 6 7 8 9 next >